文献速递消化道肿瘤放疗放疗物理与技术

食管癌放疗中中间位置策略与内靶区策略的剂量学获益比较

Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-09-22

本研究回顾性纳入15例食管癌新辅助放疗计划患者,基于10相4维CT比较中间位置(MidP)与内靶区(ITV)策略的临床靶区覆盖和危及器官剂量。14例患者两种策略的CTV V95%均>98%,MidP策略使肺、心脏和肝脏的剂量体积直方图参数显著降低约10%(P<.001)。

要点

  • 14例患者中MidP与ITV策略的CTV V95%均>98%。
  • MidP较ITV使肺、心脏、肝脏DVH参数显著降低约10%(P<.001)。
  • 计划剂量与累积4D剂量差异有限且临床无关。

核心结论

  • 与ITV策略相比,MidP策略在食管癌放疗计划中可使危及器官剂量降低约10%,同时CTV覆盖充分。

研究设计与样本

  • 回顾性纳入15例食管癌患者进行新辅助放疗计划。
  • 每例患者采集10相4维CT(4D-CT),在20%相位勾画CTV和危及器官。
  • 基于20%相位与其他9相位的可变形图像配准重建MidP-CT,并据此构建ITV。
  • 分别用MidP和ITV策略制定治疗计划生成计划剂量,再应用于10相4D-CT计算各相位剂量分布,经可变形配准形变并平均得到累积4D剂量。
  • 比较计划剂量与累积4D剂量,以及MidP策略与ITV策略的CTV覆盖和危及器官剂量。

主要发现

  • 计划剂量与累积4D剂量之间的差异有限且临床无关。
  • 14例患者中,MidP和ITV两种策略的CTV V95%均>98%。
  • 与ITV策略相比,MidP策略使肺、心脏和肝脏的剂量体积直方图参数显著降低约10%(P<.001,Wilcoxon符号秩检验)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Both midposition (MidP) and internal target volume (ITV) strategies can take the respiration-induced target motion into account. This study aimed to compare these 2 strategies in terms of clinical target volume (CTV) coverage and dose to organs at risk (OARs) for esophageal cancer radiation therapy (RT). METHODS AND MATERIALS: Fifteen patients with esophageal cancer were included retrospectively for neoadjuvant RT planning. Per patient, a 10-phase, 4-dimensional (4D) computed tomography (CT) scan (4D-CT) was acquired with CTV and OARs delineated on the 20% phase. The MidP-CT scan was reconstructed based on deformable image registration between the 20% phase and the other 9 phases; thereby, the CTV and OARs delineations were propagated and an ITV was constructed. Both MidP and ITV strategies were used for treatment planning, yielding the planned dose. Next, these plans were applied to the 10-phase 4D-CT to calculate the dose distribution for each phase of the 4D-CT. On the basis of the deformable image registration, these calculated dose distributions were warped and averaged to yield the accumulated 4D dose. Subsequently, we compared, in terms of CTV coverage and dose to OARs, the planned dose with the accumulated 4D dose and the MidP strategy with the ITV strategy. RESULTS: The differences between the planned dose and the accumulated 4D dose were limited and clinically irrelevant. In 14 patients, both MidP and ITV strategies showed V95% > 98% for the CTV. Compared with the ITV strategy, the MidP strategy showed a significant reduction of approximately 10% in the dose-volume histogram parameters for the lungs, heart, and liver (P < .001, Wilcoxon signed-rank test). CONCLUSIONS: Compared with the ITV strategy, the MidP strategy in treatment planning can lead to a reduction of approximately 10% in the dose to OARs, with an adequate CTV coverage for esophageal cancer RT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Jin P, Machiels M, Crama KF, et al. Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 30253234. doi:10.1016/j.ijrobp.2018.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。